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Predicting the chances of a live birth after one or more complete 
cycles of in vitro fertilisation: population based study of linked 
cycle data from 113 873 women
David J McLernon,1 Ewout W Steyerberg,2 Egbert R te Velde,2 Amanda J Lee,1 Siladitya Bhattacharya3 
ABSTRACT
ObjeCtive
To develop a prediction model to estimate the chances 
of a live birth over multiple complete cycles of in vitro 
fertilisation (IVF) based on a couple’s specific 
characteristics and treatment information.
Design
Population based cohort study.
setting
All licensed IVF clinics in the UK. National data from the 
Human Fertilisation and Embryology Authority register.
PartiCiPants
All 253 417 women who started IVF (including 
intracytoplasmic sperm injection) treatment in the UK from 
1999 to 2008 using their own eggs and partner’s sperm.
Main OutCOMe Measure
Two clinical prediction models were developed to 
estimate the individualised cumulative chance of a 
first live birth over a maximum of six complete cycles of 
IVF—one model using information available before 
starting treatment and the other based on additional 
information collected during the first IVF attempt. A 
complete cycle is defined as all fresh and  frozen-
thawed embryo transfers arising from one episode of 
ovarian stimulation.
results
After exclusions, 113 873 women with 184 269 complete 
cycles were included, of whom 33 154 (29.1%) had a 
live birth after their first complete cycle and 48 925 
(43.0%) after six complete cycles. Key pretreatment 
predictors of live birth were the woman’s age (31 v 37 
years; adjusted odds ratio 1.66, 95% confidence 
interval 1.62 to 1.71) and duration of infertility (3 v 6 
years; 1.09, 1.08 to 1.10). Post-treatment predictors 
included number of eggs collected (13 v 5 eggs; 1.29, 
1.27 to 1.32), cryopreservation of embryos (1.91, 1.86 to 
1.96), the woman’s age (1.53, 1.49 to 1.58), and stage 
of embryos transferred (eg, double blastocyst v double 
cleavage; 1.79, 1.67 to 1.91). Pretreatment, a 30 year 
old woman with two years of unexplained primary 
infertility has a 46% chance of having a live birth from 
the first complete cycle of IVF and a 79% chance over 
three complete cycles. If she then has five eggs 
collected in her first complete cycle followed by a 
single cleavage stage embryo transfer (with no 
embryos left for freezing) her chances change to 28% 
and 56%, respectively.
COnClusiOns
This study provides an individualised estimate of a 
couple’s cumulative chances of having a baby over a 
complete package of IVF both before treatment and 
after the first fresh embryo transfer. This novel resource 
may help couples plan their treatment and prepare 
emotionally and financially for their IVF journey.
Introduction
In the United Kingdom, one in six couples experience 
difficulties conceiving.1  In vitro fertilisation (IVF) is the 
recommended treatment of choice for all couples with 
continued unresolved fertility problems.2  By the end of 
2013 over five million people were born as a result of 
IVF or intracytoplasmic sperm injection (ICSI).3
Although the success of IVF and ICSI has convention-
ally been reported as the livebirth rate in a single fresh 
cycle,4 5  widespread use of embryo cryopreservation in 
the past two decades has meant that cumulative live-
birth rates, which include frozen embryo replacements 
as well as subsequent treatment episodes, are more 
informative, as they empower couples and clinicians to 
make strategic decisions about care over a period of 
time.6  However, cumulative livebirth rates are often 
reported either as one overall average rate or stratified 
by the woman’s age or type of infertility at a national or 
IVF clinic level.7-11  Given that many other patient and 
treatment characteristics can affect the success of IVF 
or ICSI,12 it can be difficult for clinicians to counsel cou-
ples as to their individualised chances of success over a 
complete package of IVF or ICSI treatment.
A clinical prediction model that could estimate the 
cumulative chances of a live birth before IVF or ICSI 
begins and that could provide a revised estimate of the 
WhAT IS AlReAdy knoWn on ThIS TopIC
Although the success of in vitro fertilisation (IVF) has generally been reported as the 
livebirth rate in a single fresh embryo transfer, the increase in embryo 
cryopreservation has meant that cumulative livebirth rates are more informative
Previous prediction models have either only estimated the individualised chances 
of a live birth after a single fresh embryo transfer or ignored the contribution of 
frozen embryo transfers to the cumulative chances of a live birth
Failure to take account of all embryo transfer attempts has meant that such 
prediction models have not proved to be useful as counselling tools as the first 
treatment does not always succeed
WhAT ThIS STudy AddS
Our novel prediction models estimate the cumulative chances of a live birth over six 
complete cycles (including replacement of fresh and frozen embryos) of IVF before 
treatment and after the first fresh embryo transfer attempt
The cumulative aspect of our prediction models will aid clinicians by supporting 
their clinical knowledge when communicating to couples their personalised 
chances of a live birth over an entire package of IVF treatment. 
The cumulative aspect of our prediction models will also help couples plan their 
time and prepare emotionally and financially for their complete IVF journey
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expected outcomes after one or more treatment cycles 
would be critical for patient counselling and informing 
decision making in IVF. No such model currently exists. 
We therefore estimated the predicted cumulative prob-
ability of a first live birth over multiple complete cycles 
of IVF or ICSI at initial consultation before treatment 
starts (pretreatment) and after the first attempt at fresh 
embryo transfer, when treatment specific information is 
available (post-treatment).
Methods
Database
The Human Fertilisation and Embryology Authority 
(HFEA) has collected data on all licensed fertility treat-
ments in the UK since 1992. An anonymised HFEA data-
base is freely available online for research purposes.13-16 
This version only contains data at the individual (fresh 
or frozen) IVF treatment level, with no link between 
treatment and individual women—a requirement when 
estimating the cumulative probability of a live birth. 
However, a more detailed version of the HFEA database 
is available for research purposes under strict condi-
tions, which links all IVF treatments to complete cycles 
and to individual women and allows estimation of the 
cumulative probability of a live birth.15 17 Following 
approval by the North of Scotland research ethics com-
mittee, the Confidentiality Advisory Group, and the 
HFEA register research panel, anonymised data on all 
treatments linked to each woman undergoing IVF or 
ICSI were made available to the authors.
study population
In this population based cohort study, records of all 
complete IVF and ICSI cycles—defined as all attempts at 
fresh and frozen embryo transfer resulting from one epi-
sode of ovarian stimulation—in women who started 
their first ovarian stimulation in the UK between Janu-
ary 1999 and September 2008 were extracted up until 
September 2009 when exposure to IVF ended. Data 
from October 2009 onwards were not included in the 
analysis because consent for patient data on IVF or ICSI 
to be used in research changed from “presumed” to 
“required” at that point. Including such years would 
have led to falsely higher discontinuation rates owing 
to women opting not to disclose their treatment infor-
mation in later complete cycles. Women who had any 
element of treatment involving donor insemination, egg 
donation, and surrogacy were not included in the 
requested database. Supplementary figure A1 details 
further exclusion criteria made on receipt of the data.
baseline characteristics
Baseline characteristics of couples included the wom-
an’s age, duration of infertility (years), type of infertility 
(categorised as diagnosis of tubal, endometriosis, 
anovulation, male factor, or unexplained), previous 
pregnancy status of the couple (yes versus no), treat-
ment type (ICSI versus IVF), and year of first egg 
retrieval. Treatment level characteristics from the 
attempt at fresh embryo transfer of the first complete 
cycle included number of eggs collected, number of 
embryos transferred, stage of embryo transfer (cleavage 
versus blastocyst), and whether embryos were frozen 
(cryopreservation of embryos).
Outcome
We estimated the cumulative chances of a first live 
birth for a couple having up to six complete cycles of 
IVF. One complete cycle included all fresh and frozen 
embryo transfers resulting from one episode of ovarian 
stimulation.
statistical analysis
We developed two clinical prediction models to use 
before and after treatment.
Pretreatment model—for a couple about to embark on 
IVF or ICSI, we estimated the cumulative probability of 
a live birth over a maximum of six complete cycles 
using the characteristics of the couple and whether 
they planned to undergo IVF or ICSI.
Post-treatment model—to update the cumulative 
probability of live birth after the first attempt at embryo 
transfer, we included treatment specific characteristics 
from the first complete cycle along with the characteris-
tics of the couple from the pretreatment model.
Model development
We used a discrete time logistic regression model to pre-
dict the chance of a live birth after a maximum of six 
cumulative complete cycles of IVF or ICSI, where a com-
plete cycle included a fresh embryo transfer and any 
associated frozen-thawed embryo transfers. To assess the 
predicted probability of a live birth in the ith complete 
cycle conditional on no live birth having occurred before 
that complete cycle, we treated the complete cycle num-
ber as a discrete time variable. From this model, we cal-
culated the cumulative probability of a live birth over 
sequential complete cycles up to complete cycle 6.
Initially we fitted univariable models to assess the 
effect of individual predictors (adjusting for complete 
cycle number) on live birth. The woman’s age, treat-
ment year, and number of eggs retrieved all had non- 
linear relations with the probability of a live birth so 
were modelled using restricted cubic splines. Effect esti-
mates were presented for the interquartile range (25th v 
75th centile values, or 75th v 25th centile values).18
A manual backward selection process was used to 
determine the final multivariable discrete time logistic 
regression model to predict live birth over successive 
complete cycles of IVF or ICSI. In this procedure, com-
plete cycle number, the woman’s age, duration of 
 infertility, and number of eggs collected (for post-treat-
ment model only) were always included and could not 
be removed because these are known predictors of preg-
nancy outcomes after IVF.12  All of the other available 
predictors (listed as baseline characteristic) were sub-
jected to the selection process. Women who had no eggs 
collected were excluded from the post-treatment model 
because it would not be possible to achieve a live birth in 
the first complete cycle. Therefore we fitted a separate 
model for these women. Since IVF centres have varying 
success rates, we also considered a random intercept for 
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the effect of IVF centre as recommended in recent stud-
ies.19 20 To quantify variation between centres, we calcu-
lated the 95% range for centre effect.
Missing data
Where data were missing for any predictor, we com-
pared the characteristics of women with complete data 
with those for women with missing data. Single imputa-
tion was performed for those predictors with missing 
information. This procedure assumes that missingness 
was random, conditional on the observed predictors 
and outcome.
Predictive ability
To determine the explanatory value of each predictor 
relative to the entire set we calculated the adequacy 
 statistic.21  The adequacy is the proportion of the total 
explained variation in the outcome that is explained by 
the individual predictor.22
We used the C index to assess the ability of the multi-
variable models to discriminate between couples at 
high and low chances of a live birth.23 Because the per-
formance of the models with and without the random 
effect of centre were shown to be similar, we considered 
the fixed effects model to be the final model.
To assess whether the model calibration was too opti-
mistic within the database from which the model was 
developed, we used bootstrapping for internal valida-
tion (see supplementary text S1).18  By internally vali-
dating the calibration slope of the model we could 
determine whether the model underestimated or over-
estimated predictions.18 A perfect slope should equal 1.
Treatment continuation
A further analysis was done to investigate the effect of 
predictors on continuing to a second complete cycle of 
IVF in women who did not have a live birth in complete 
cycle 1. The methods and results of this are reported in 
the appendix (see supplementary text S2). Statistical 
analysis was carried out using SAS (V.9.3) (SAS Insti-
tute, Cary, NC).
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
developing plans for design or implementation of the 
study. No patients were asked to advise on interpreta-
tion or writing up of results. There are plans to dissemi-
nate the results of the research to patients affected by 
fertility issues via national fertility charities and the 
Human Fertilisation and Embryology Authority.
Results
After exclusions, the dataset included 113 873 couples 
who underwent 184 269 complete cycles of IVF or ICSI 
(see supplementary figure A1). Table 1  shows the distri-
bution of the characteristics of the couples and those of 
their first complete cycle (defined as all fresh and frozen 
embryo transfers resulting from one episode of ovarian 
stimulation), which resulted in a live birth in 33 154 
(29%) women (fig 1). Of the remaining 80 719 couples 
only 45 384 (56%) went on to have a second complete 
cycle. Overall, 43% of couples had a live birth over the 
first six complete cycles of IVF or ICSI. The median time 
to follow-up for those not having a live birth was 1515 
days (interquartile range 669-2631). Thirty per cent of all 
live births were multiples. Supplementary text S1 pro-
vides detailed information on missing data.
Predicting the cumulative chances of a live birth
Individually, all patient and treatment level character-
istics had statistically significant univariable associa-
tions with live birth, except for unexplained infertility 
(see supplementary table A1). Figure 2 shows the unad-
justed relation between the predicted probability of live 
birth in the first complete cycle and the woman’s age, 
duration of infertility, treatment year, and number of 
table 1 | Characteristics of couples and their treatment at first complete cycle of in vitro 
fertilisation (ivF). values are numbers (percentages) unless stated otherwise
Characteristics Data
No of women 113 873
No of complete cycles 184 269
Patient characteristics
Mean (SD) age of women 34.1 (5)
Median (interquartile range) duration of infertility (years) 4 (3-6)
 Missing 18 225 (16)
No previous pregnancy in couple 75 541 (66)
Previous pregnancy in couple 28 070 (25)
 Missing* 10 262 (9)
Type of infertility:
 Tubal 26 545 (23)
 Anovulatory 15 942 (14)
 Male factor 49 753 (44)
 Unexplained 32 693 (29)
 Endometriosis 7590 (7)
 >1 type 13 414 (12)
Year of first egg retrieval:
 1999-2001 29 451 (26)
 2002-04 34 472 (30)
 2005-08 49 950 (44)
treatment characteristics at complete cycle 1
IVF 67 511 (59)
Intracytoplasmic sperm injection 46 362 (41)
Median No (interquartile range) of eggs collected 8 (5-13)
Median No (interquartile range) of embryos created 5 (2-8)
Median No (interquartile range) of embryos frozen 0 (0-1)
Cryopreservation of embryos 28 950 (25)
No of frozen treatments:
 0 103 726 (91)
 1 8270 (7)
 2 1568 (1)
 3 246 (0.2)
 ≥4 63 (0.1)
No of embryos transferred and stage, first fresh treatment:
 No transfer 15 501 (14)
 Single cleavage stage 9248 (8)
 Single blastocyst stage 662 (1)
 Double cleavage stage 75 701 (66)
 Double blastocyst stage 2960 (3)
 Triple cleavage stage 8649 (8)
 Triple blastocyst stage 130 (0.1)
 Missing 1022 (1)
*Missing values for previous pregnancy occurred in 2008. Since only 13% were recorded as not having a previous 
pregnancy in 2008 the whole year was imputed.
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eggs collected. The chances of a live birth declined after 
age 30 and decreased linearly with increasing duration 
of infertility. Increasing egg numbers improved the 
chance of live birth considerably until 13 eggs. Year of 
treatment showed a positive effect from 2006 onwards.
Pretreatment model
The factors that predicted the cumulative chances of 
having a live birth over a maximum of six complete 
cycles (in a multivariable model) were the woman’s age, 
duration of infertility, treatment type, year, tubal infer-
tility, male factor infertility, unexplained infertility, 
anovulation, and previous pregnancy, with age explain-
ing 85% of the total variation explained by all the fac-
tors (table 2 and supplementary table A2). The odds of a 
live birth decreased with every increasing complete 
cycle—eg, the odds of a live birth after complete cycle 2 
was 21% lower than the odds of a live birth after com-
plete cycle 1, and the odds after complete cycle 6 were 
56% less than after complete cycle 1. With increasing 
woman’s age the odds of a live birth over six complete 
cycles decreased (31 v 37 years; adjusted odds ratio 1.66, 
95% confidence interval 1.62 to 1.71). Increasing dura-
tion of infertility reduced the odds of a live birth (3 v 6 
years; 1.09, 1.08 to 1.10). Couples with a diagnosis of 
tubal or male factor infertility had around a 10% 
reduced chance of a live birth, whereas couples with 
No further IVF during follow-up
(n=35 335; 31·0)
Cycle 2
(n=45 384; 39·9)
Cycle 1
(n=113 873)
Live birth
(n=33 154; 29·1)
No further IVF during follow-up
(n=18 026; 39.7)
Cycle 3
(n=16 473; 36.3)
Live birth
(n=10 885; 24.0)
No further IVF during follow-up
(n=7481; 45.4)
Cycle 4
(n=5551; 33.7)
Live birth
(n=3441; 20.9)
No further IVF during follow-up
(n=2625; 47.3)
Cycle 5
(n=1891; 34.1)
Live birth
(n=1035; 18.6)
No further IVF during follow-up
(n=898; 47.5)
Cycle 6
(n=684; 36.2)
Live birth
(n=309; 16.3)
No further IVF during follow-up
(n=325; 47.5)
Cycle 7
(n=258; 37.7)
Live birth
(n=101; 14.8)
Fig 1 | number of women having a live birth, not having a live birth but continuing in vitro 
fertilisation (ivF), or not having a live birth and not continuing ivF (during follow-up) over 
six complete cycles of ivF
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Fig 2 | Plots showing unadjusted (univariable) relations between the following continuous baseline variables and a live 
birth in the first complete cycle of in vitro fertilisation. (a) Woman’s age (years); (b) duration of infertility (years); (C) year 
of first complete cycle, and (D) number of eggs retrieved in first complete cycle. each panel depicts the probability of live 
birth (solid curve) with 95% confidence bands as a function of the baseline variable. the degrees of freedom (df) 
associated with the χ2 statistic in each case depend on the complexity of the relation between the variable and the log 
odds of live birth. Where df >1, the relation was non-linear and characterised by restricted cubic spline functions. Where 
df=1, the relation was linear even though the plot shown here, which reflects live birth (rather than the log odds), exhibits 
a non-linear relation 
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unexplained infertility or anovulation had slightly 
increased chances of success. Couples without a previ-
ous pregnancy had slightly decreased odds of live birth 
(0.93, 0.90 to 0.95). Couples who underwent ICSI had a 
24% increased chance of a live birth than those who 
underwent IVF.
Post-treatment model
After the first fresh embryo transfer, the odds of a live 
birth increased with egg number, doubled in cases 
where embryos were cryopreserved, and decreased by 
9% if the treatment was ICSI (table 3). The chances of a 
live birth over six complete cycles were lower after 
transfer of a single cleavage stage fresh embryo com-
pared with transfer of a double cleavage stage fresh 
embryo. The effects of the predictors which also 
appeared in the pretreatment model were similar, apart 
from ICSI compared with IVF. Woman’s age, cryopreser-
vation of embryos, and number of eggs each explained 
a similar high amount of the total variation explained 
by all the factors (see supplementary table A3). Supple-
mentary table A4 shows the results for women who had 
no eggs collected.
assessing ability to predict cumulative live birth
The C index for the pretreatment model was 0.73 (0.72 to 
0.74) and for the post-treatment model was 0.72 (0.71 to 
0.73). The optimism adjusted calibration slope in both 
models was almost one (0.996 and 0.998, respectively) 
suggesting no overfitting of predictor effects.
examples of predicting cumulative live birth for 
specific couples
Figure 3 shows an example of pretreatment predic-
tions in different case scenarios. Part A shows the 
cumulative predicted probability of live birth over six 
complete cycles for couples starting ICSI for male fac-
tor infertility. The figure shows the probabilities for 
women aged 30 and 40 with either two or five years of 
infertility. While duration is less influential, younger 
women have a much higher chance of success, with a 
probability of 0.47 in complete cycle 1 (with two years’ 
duration of infertility) increasing to 0.94 over six com-
plete cycles (0.19 to 0.57 for 40 year old women). Simi-
lar predictions were found for couples with 
unexplained infertility who underwent IVF treatment 
in their first complete cycle.
Post-treatment, the predictions for the above sce-
narios were updated using information from the fresh 
treatment of the first complete cycle. The top line from 
figure 4 represents a woman with an excellent progno-
sis—aged 30 years, non-tubal infertility, 15 eggs col-
lected, embryos cryopreserved, and a single fresh 
blastocyst transfer in the first complete cycle. The 
probability of success in complete cycle 1 is 0.68. 
Cumulatively this increases to 0.89 over two complete 
cycles and rises to just under 1 over four complete 
cycles. The lower line in the chart represents a poorer 
prognosis—a woman aged 40 who had IVF, five eggs 
collected, no embryos frozen, and a single cleavage 
stage fresh embryo transferred in the first complete 
table 2 | effect and importance (in decreasing order) of each predictor on live birth over 
multiple complete cycles of in vitro fertilisation (ivF) adjusted for patient characteristics 
(pretreatment model)
Predictors Odds ratio (95% Ci) P value adequacy
Intercept <0.001
Complete cycle No:
 1 (reference) 1
 2 0.79 (0.77 to 0.81) <0.001
 3 0.66 (0.64 to 0.69) <0.001
 4 0.57 (0.53 to 0.61) <0.001
 5 0.49 (0.43 to 0.55) <0.001
 6 0.44 (0.36 to 0.55) <0.001
Patient characteristics:
 Woman’s age, 31 v 37 years* 1.66 (1.62 to 1.71) <0.001 0.846
 Duration, 3 v 6 years 1.09 (1.08 to 1.10) <0.001 0.078
 Treatment type, ICSI v IVF 1.24 (1.21 to 1.28) <0.001 0.047
 Year first complete cycle started, 2006 v 2001* 1.20 (1.16 to 1.24) <0.001 0.032
 Tubal infertility, yes v no 0.91 (0.88 to 0.94) <0.001 0.012
 Male factor infertility, yes v no 0.90 (0.87 to 0.94) <0.001 0.009
 Unexplained infertility, yes v no 1.06 (1.03 to 1.10) <0.001 0.001
 Anovulatory infertility, yes v no 1.05 (1.01 to 1.09) 0.01 0.001
 Previous pregnancy in couple, no v yes 0.93 (0.90 to 0.95) <0.001 0.0002
ICSI=intracytoplasmic sperm injection.
*Interquartile odds ratio was calculated to aid interpretation of continuous predictors of age, duration of 
infertility, and year first complete cycle started. It is defined as the ratio of the odds of a live birth for the 75th 
centile and the odds of a live birth for the 25th centile of the predictor.
Nagelkerke’s R2 (amount of explained variation in model)=7.9%; Tjur’s coefficient of discrimination=5.1%.
table 3 | effect and importance (in decreasing order) of each predictor on live birth over 
multiple complete cycles of in vitro fertilisation (ivF) adjusted for patient characteristics 
and treatment information at first complete cycle (post-treatment model)
Predictors Odds ratio (95% Ci) P value adequacy
Intercept <0.001
Complete cycle No:
 1 (Reference) 1
 2 0.82 (0.80 to 0.85) <0.001
 3 0.70 (0.67 to 0.73) <0.001
 4 0.60 (0.56 to 0.65) <0.001
 5 0.51 (0.44 to 0.58) <0.001
 6 0.46 (0.37 to 0.58) <0.001
Patient characteristics
Woman’s age to 31 v 37 years* 1.53 (1.49 to 1.58.) <0.001 0.435
Duration to 3 v 6 years 1.06 (1.05 to 1.08) <0.001 0.036
Year first complete cycle started to 2006 v 2001* 1.29 (1.26 to 1.32) <0.001 0.018
Tubal infertility to yes v no 0.80 (0.78 to 0.83) <0.001 0.007
Previous pregnancy in couple to no v yes 0.95 (0.93 to 0.98) <0.001 0.0001
treatment information at first complete cycle
Cryopreservation of embryos to yes v no 1.91 (1.86 to 1.96) <0.001 0.387
No of eggs collected to 13 v 5* 1.29 (1.27 to 1.32) <0.001 0.378
Stage of embryos transferred: <0.001 0.123
 Double cleavage 1
 No embryos transferred 0.34 (0.32 to 0.36) <0.001
 Single cleavage 0.57 (0.54 to 0.60) <0.001
 Single blastocyst 1.07 (0.93 to 1.24) 0.35
 Double blastocyst 1.79 (1.67 to 1.91) <0.001
 Triple cleavage 1.02 (0.98 to 1.07) 0.36
 Triple blastocyst 1.58 (1.15 to 2.14) 0.004
Treatment type to ICSI v IVF 0.91 (0.89 to 0.93) <0.001 0.002
ICSI=intracytoplasmic sperm injection.
*Interquartile odds ratio was calculated to aid interpretation of continuous predictors of age, duration of 
infertility, year first complete cycle started, and eggs collected. It is defined as the ratio of the odds of a live birth 
for the 75th centile and the odds of a live birth for the 25 centile of the predictor.
Nagelkerke’s R2 (amount of explained variation in model)=14.7%; Tjur’s coefficient of discrimination=510.3%.
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cycle. Her chance of a live birth is 0.11 in complete 
cycle 1 increasing to 0.20 over two complete cycles 
(0.41 over six). See supplementary text S3 for the for-
mulas used to calculate the individualised cumulative 
predictions.
sensitivity analyses
The effects from both models fitted using couples with 
complete data only were similar to those from the 
imputed models (see supplementary tables A5-A7).
In centres with low birth rates (2.5th centile of the 
random effect distribution), the odds of a live birth were 
0.61 times that of the average, whereas in centres with 
high livebirth rates (97.5th centile) the odds of a live 
birth were 1.65 times the average, after adjustment for 
the post-treatment predictors. The predictor effects 
from the models with the random intercept were similar 
to those from the fixed effects only model (see supple-
mentary tables A8 and A9). The C indices were similar 
when fixed (from fixed effects model), marginal, or con-
ditional (from random effects model) estimates of the 
predicted probabilities were used. A random slope for 
centre had no statistically significant effect.
discussion
We have estimated the individualised chances of having 
a liveborn baby over a complete package of in vitro fer-
tilisation (IVF) or intracytoplasmic sperm injection 
(ICSI) treatment at two time points. In couples embark-
ing on IVF or ICSI we found that increasing age of the 
woman (from 30 years) was far the best predictor of live 
birth. After transfer of a fresh embryo in the first com-
plete cycle, aside from the woman’s age, increasing 
number of eggs collected and the cryopreservation of 
embryos were the next best predictors.
strengths and weaknesses of this study
This study successfully predicted the chances of cumu-
lative live birth over six complete cycles of IVF or ICSI 
using personalised information from national data over 
10 years.
Treatment year was highly associated with live birth, 
signifying improvements in technology over time. Since 
the last year in our study period was 2008, we checked 
for underestimation of predictions owing to improve-
ments in assisted conception since 2008. This was done 
by inflating the predictions from 2008 in the model to 
2013, the latest year with published national livebirth 
rates on the Human Fertilisation and Embryology 
Authority website.24  The livebirth rate for each treat-
ment cycle started using the woman’s own fresh eggs 
was 25.8% in 2008, and reduced to 25.2% in 2009 before 
slowly rising back to 25.8% in 2012.25 In 2013 the rate 
increased to 26.5%. The intercept of the model was 
inflated by the difference between the 2008 and 2013 
rates (on the log odds scale). Such an adjustment 
increased the predicted probabilities by up to a maxi-
mum of 0.009 (and by a mean of 0.007). In our new 
online calculator (https://w3.abdn.ac.uk/clsm/opis), 
predictions are computed using the 2013 estimate.
Unlike previous studies, we investigated heterogene-
ity in IVF centre effects using random effect intercepts 
as we had anonymised centre identifiers. Although 
there was some variation in the odds of live birth across 
centres, the ability of the model to predict using predic-
tions conditioned on centres from the random effects 
model were no better than using standard estimates 
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Fig 3 | example of pretreatment model predicting cumulative 
probability of live birth over six complete cycles of in vitro 
fertilisation (ivF) for women aged 30 or 40 with two or five 
years of primary infertility who have: (a) male factor 
infertility and had treatment by intracytoplasmic sperm 
injection; (b) unexplained infertility and underwent ivF
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Fig 4 | example of post-treatment model predicting 
cumulative probability of live birth over six complete cycles 
of in vitro fertilisation (ivF) for different patient and 
treatment characteristics (these patients have all had 
primary infertility for two years) 
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from the fixed effects model without adjustment for 
centre. Therefore, for reasons of generalisability, and 
because centre was anonymous, we advise using the 
fixed effects models.
Two models have been developed that may be used 
by clinicians at two different time points to estimate a 
couple’s chances of having a live birth over one or more 
complete cycles of IVF. At these particular times points 
(before IVF and after first transfer of a fresh embryo) 
only information on the couple and treatment available 
at those times can be used to make predictions. There-
fore at the point when the pre-IVF model will be used by 
clinicians to counsel couples as to their future chances 
of success, the woman’s age, duration of infertility, type 
of infertility, previous pregnancy status of the couple, 
and treatment type are known. The post-IVF model 
revises these estimates using updated information from 
the first attempt at a fresh embryo transfer. We acknowl-
edge that information from future complete cycles 
would provide more precise predictions, but our mod-
els reflect a more real life setting where such informa-
tion is not available at the time of counselling. These 
models will provide an indication of the couple’s future 
chances of achieving a live birth over a complete pack-
age of IVF at the beginning of treatment.
One limitation concerns the effect of calendar time on 
future frozen embryo transfers in the first complete cycle. 
For example, a woman may decide to have a frozen 
embryo transfer five years after the embryos were frozen. 
However, unless there were changes to her uterine envi-
ronment, time is unlikely to decrease her chance of a live 
birth as the embryos were created using eggs retrieved 
five years earlier. Furthermore, we did not adjust for the 
time between complete cycles of IVF or ICSI nor for the 
change in predictors with each sequential complete 
cycle. The reason for this is because such information is 
not known at the time predictions are made.
We were unable to adjust for other potentially import-
ant predictors that were not available in the HFEA data-
set. These include body mass index of the woman, 
ethnicity, smoking status, alcohol intake, and measures 
of ovarian reserve such as antral follicle count. A sys-
tematic review concluded that women’s age, duration 
of infertility, number of eggs collected, and basal folli-
cle stimulating hormone level were the most important 
predictors of IVF or ICSI success.12  Of these, only the 
last predictor was unavailable in our analysis. Smoking 
and alcohol consumption in both sexes have been 
shown to have an association with IVF success.26-28 
Although the availability of these potential predictors 
would have been valuable, the quality and complete-
ness of routinely collected data on smoking and alcohol 
is questionable owing to being self reported.29 30
One of the model assumptions was that those cou-
ples who discontinue treatment without a live birth still 
have the same chance of a live birth as those who con-
tinue, after correction for predictor effects. This 
assumption only applies to women with obvious barri-
ers to continuing treatment, such as a lack of funds, 
divorce, or death. However, most discontinue because 
they have a lower chance of success.31  The reason for 
treatment withdrawal was unfortunately not available. 
Studies have tried to discount optimal estimates by the 
same fixed percentage across all individuals.11 32 How-
ever, such an approach is flawed because the chances of 
continuing treatment are highly likely to vary widely 
depending on a couple’s characteristics (see supple-
mentary text S2). By using a modelling approach to pre-
dict cumulative live birth we have adjusted for treatment 
continuation based on the covariates (such as the wom-
an’s age) as available.
Internal validation of the models showed that the 
optimism in the calibration slopes was minimal (owing 
to the large sample size). Because our model was devel-
oped using the UK national IVF registry database with 
the intention of being used in the UK there is no urgent 
need to externally validate on data from another geo-
graphical location,33 especially since IVF practice and 
policy varies across countries. Before the model is 
applied in other settings we recommend validation, 
specifically an assessment of the calibration of the 
model predictions. In the future, temporal validation 
on an up-to-date UK database is important to ensure 
that the model is robust to changes in UK IVF policy. 
Further work will involve sourcing a suitable database 
with which to carry out such a study.
strengths and weaknesses in relation to previous 
studies
Many studies have reported the chance of a live birth 
after IVF or ICSI.13 34-36  However, for different reasons 
they do not predict cumulative live birth over multiple 
complete cycles of IVF or ICSI. They either make predic-
tions for the first transfer of a fresh embryo only,34  make 
predictions for individual embryo transfer episodes but 
with no linkage between cycle and woman (a necessary 
requirement for calculating cumulative outcomes over 
multiple cycles),13  or only adjust for the number of pre-
vious failed cycles.36  One study37  produced a similar 
model to ours, but this did not reflect usual practice as 
it only made cumulative predictions up to three fresh 
embryo transfer attempts and excluded any associated 
frozen embryo transfers. In an age where the emphasis 
is on reducing multiple births and increasing single 
embryo transfers,2  a complete cycle definition aids 
interpretability of results for clinicians and couples 
who want to know the chances of a live birth over an 
entire IVF programme.38
For fertility models, calibration in an external cohort 
tends to be the more important measure of performance 
than discrimination owing to the homogeneity of the 
population being studied.39 Discrimination assess-
ments tend to result in C indices of around 0.65 at best. 
However, the C index for both models is, as far as we 
know, the highest found for IVF models to date. This 
might be due to the large sample size, carefully captur-
ing non-linearity, the effect of complete cycle number, 
or a combination of the three.
interpretation and clinical importance
These are the first models to predict individualised 
chances of live birth over a course of complete IVF cycles. 
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The results are relevant not only for individual couples 
and their clinicians but also for funders and policy mak-
ers in determining access to state or insurance funded 
IVF.2 The models have been converted into an online cal-
culator that can be used to estimate the probability of live 
birth based on the characteristics of the couple and treat-
ment (https://w3.abdn.ac.uk/clsm/opis).
The most appropriate use of these models is to 
serve as a counselling tool to help shape expectations 
for couples who would ideally like to know their over-
all chance of having a baby over a complete IVF or 
ICSI journey. As an example, the probability of a live 
birth in the first complete cycle for a couple with pri-
mary unexplained infertility for two years and the 
woman aged 30 undergoing IVF is 0.46 (0.93 over six 
complete cycles). After transfer of a single cleavage 
embryo following the collection of five eggs and no 
embryos cryopreserved, the probability decreases to 
0.29 (0.78 over six complete cycles). Before treatment 
is started, clinicians would use these predictions to 
support their clinical knowledge when communicat-
ing to couples their chance of successful treatment 
over a complete IVF programme. Following the first 
embryo transfer, when treatment information is avail-
able, clinicians can then use the revised predictions 
to offer reassurance to couples about their future 
chances over multiple complete cycles. Existing mod-
els that only inform the chances of a liveborn baby 
after the first fresh cycle are not useful because the 
first treatment does not always succeed. The results 
from our model might help couples plan their time 
and prepare emotionally and financially for their 
complete IVF journey.
Currently we do not advise that these models be used 
to make decisions around whether or not couples 
should have IVF treatment. The reason for this is 
because their impact on clinical pathways, health out-
comes, and costs need to be investigated and shown to 
be beneficial before doctors and couples can be per-
suaded to use them for decision making.40 41  Further-
more, for a model to be truly useful for decisions around 
whether or not to treat it needs to provide estimates of 
the change in the absolute benefit of treatment over 
time, which would require information on couples 
under expectant management—that is, do not receive 
treatment.42 Unfortunately, such information is not 
available in the HFEA database or elsewhere at a 
national level.
We confirmed the reduction in the chance of live 
birth with increasing age, increasing duration of infer-
tility, and previous pregnancy.13 35 36 Before starting 
IVF or ICSI, unexplained infertility and anovulation 
were associated with an increased chance of live birth, 
whereas male factor and tubal infertility had a nega-
tive association. However, apart from tubal infertility 
these associations disappeared when predictions were 
updated using additional information from the first 
fresh embryo transfer. This suggests that treatment 
information overrides the effect of the different types 
of infertility—women with a high number of eggs who 
have cryopreserved embryos might reflect mild infer-
tility encompassing most women in the unexplained, 
male factor, and anovulation categories.
Further research
In addition to temporal validation, external validation 
on national registry data from other countries might 
realise the potential of our models to be recalibrated (if 
required) and used in those populations.
Conclusions
Many couples with fertility problems embarking on IVF 
will undergo several complete cycles—each involving a 
fresh embryo transfer potentially followed by one or 
more frozen embryo transfers in order to achieve their 
first live birth. This study has developed a novel calcu-
lator that can predict the cumulative chances of a live 
birth for an individual couple over a package of com-
plete IVF cycles. This tool will help to shape couples’ 
expectations allowing them to plan their treatments 
more efficiently and to prepare emotionally and finan-
cially.
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